How to cite item

Adjuvant treatment for EGFR-mutated non-small cell lung cancer: do we have a major breakthrough?

   
@article{JTD22351,
	author = {Giandomenico Roviello and Marco Imperatori and Michele Aieta and Francesco Sollitto and Matteo Landriscina},
	title = {Adjuvant treatment for EGFR-mutated non-small cell lung cancer: do we have a major breakthrough?},
	journal = {Journal of Thoracic Disease},
	volume = {10},
	number = {Suppl 18},
	year = {2018},
	keywords = {},
	abstract = {Zhong et al. reported the results of the ADJUVANT/CTONG1104 study (1), a randomized open-label phase III trial enrolling 483 Chinese patients with completely resected (R0) stage II–IIIA (N1-N2) non-small cell lung cancer (NSCLC) and epidermal growth factor receptor (EGFR)-mutant (defined as exon 19 deletion or exon 21 Leu858Arg) to receive 4 cycles of standard adjuvant Cisplatin and Vinorelbine or 24 months of the EGFR-tyrosine kinase inhibitor (TKI), gefitinib. The primary end-point was disease free survival (DFS).},
	issn = {2077-6624},	url = {https://jtd.amegroups.org/article/view/22351}
}